PepGen (PEPG) News Today $1.61 +0.04 (+2.55%) Closing price 03/27/2025 04:00 PM EasternExtended Trading$1.58 -0.04 (-2.17%) As of 03/27/2025 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc - PEPGMarch 25 at 10:00 AM | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc - PEPGMarch 17, 2025 | prnewswire.comShort Interest in PepGen Inc. (NASDAQ:PEPG) Expands By 229.6%PepGen Inc. (NASDAQ:PEPG - Get Free Report) saw a large increase in short interest during the month of February. As of February 28th, there was short interest totalling 2,810,000 shares, an increase of 229.6% from the February 13th total of 852,600 shares. Based on an average trading volume of 2,690,000 shares, the short-interest ratio is currently 1.0 days. Currently, 10.3% of the shares of the stock are sold short.March 14, 2025 | marketbeat.comPepGen Announces Presentations at the 2025 Muscular Dystrophy Association Clinical & Scientific ConferenceMarch 10, 2025 | businesswire.comPepGen Inc. (NASDAQ:PEPG) Short Interest Up 26.2% in FebruaryPepGen Inc. (NASDAQ:PEPG - Get Free Report) was the target of a large increase in short interest in the month of February. As of February 15th, there was short interest totalling 852,600 shares, an increase of 26.2% from the January 31st total of 675,600 shares. Approximately 3.1% of the shares of the stock are short sold. Based on an average daily trading volume, of 2,050,000 shares, the days-to-cover ratio is currently 0.4 days.March 6, 2025 | marketbeat.comPepGen to pause CONNECT2-EDO51 studyMarch 4, 2025 | markets.businessinsider.comPepGen Announces Update to Phase 2 CONNECT2-EDO51 Study in Patients with DMDMarch 4, 2025 | finance.yahoo.comBoston biotech's stock drops after Duchenne trial pauseMarch 4, 2025 | bizjournals.comPepGen Sees Fastest Weekly Retail Following Growth Among Biotech Stocks: What's Behind The Buzz?February 28, 2025 | msn.comHC Wainwright Predicts PepGen's Q1 Earnings (NASDAQ:PEPG)PepGen Inc. (NASDAQ:PEPG - Free Report) - Equities research analysts at HC Wainwright issued their Q1 2025 EPS estimates for PepGen in a note issued to investors on Monday, February 24th. HC Wainwright analyst A. Fein expects that the company will post earnings of ($0.75) per share for the quarteFebruary 26, 2025 | marketbeat.comLeerink Partnrs Has Positive Estimate for PepGen Q1 EarningsPepGen Inc. (NASDAQ:PEPG - Free Report) - Equities researchers at Leerink Partnrs increased their Q1 2025 earnings estimates for shares of PepGen in a research note issued on Monday, February 24th. Leerink Partnrs analyst J. Schwartz now anticipates that the company will earn ($0.75) per share foFebruary 26, 2025 | marketbeat.comPepGen (PEPG) Expected to Announce Earnings on WednesdayPepGen (NASDAQ:PEPG) will be releasing earnings before the market opens on Wednesday, March 5.February 26, 2025 | marketbeat.comPepGen Inc. Reports Positive Trial Results and FinancialsFebruary 25, 2025 | tipranks.comPepGen data ‘very encouraging’ for program, says H.C. WainwrightFebruary 25, 2025 | markets.businessinsider.comPepGen data ‘very encouraging’ for program, says H.C. WainwrightFebruary 25, 2025 | markets.businessinsider.comPepGen reports positive initial data from Phase I DM1 therapy trialFebruary 25, 2025 | finance.yahoo.comPepGen reports positive initial data from Phase I DM1 therapy trialFebruary 25, 2025 | finance.yahoo.comSell Rating on PepGen Inc. Amid Clinical and Regulatory ChallengesFebruary 25, 2025 | tipranks.comPepGen announces initial clinical data from cohorts in FREEDOM-DM1 trialFebruary 25, 2025 | markets.businessinsider.comPepGen initial DM1 data ‘a clear win,’ says StifelFebruary 25, 2025 | markets.businessinsider.comPepGen Announces Positive Initial Results, Including Robust Splicing Correction, from Ongoing FREEDOM-DM1 Trial in Patients with DM1February 25, 2025 | finance.yahoo.comPenny Stocks To Watch Today - February 24thPepGen, MicroAlgo, TeraWulf, Connexa Sports Technologies, FuboTV, Bellevue Life Sciences Acquisition, and Agape ATP are the seven Penny stocks to watch today, according to MarketBeat's stock screener tool. Penny stocks are shares of small companies that typically trade at very low prices, often undFebruary 24, 2025 | marketbeat.comPepGen's (PEPG) Buy Rating Reaffirmed at HC WainwrightHC Wainwright restated a "buy" rating and set a $16.00 price objective on shares of PepGen in a research note on Monday.February 24, 2025 | marketbeat.comPromising Initial Data and Safety Profile Boost PepGen’s FREEDOM-DM1 Trial OutlookFebruary 24, 2025 | tipranks.comPepGen Inc. Announces Positive FREEDOM-DM1 Trial ResultsFebruary 24, 2025 | tipranks.comPepGen Reports Fourth Quarter and Year-End 2024 Financial Results and Recent Corporate HighlightsFebruary 24, 2025 | businesswire.comPepGen stock plunges to 52-week low at $1.16 amid market challengesFebruary 13, 2025 | msn.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPGFebruary 4, 2025 | prnewswire.comPepGen announces CONNECT program updatesJanuary 31, 2025 | markets.businessinsider.comH.C. Wainwright cuts PepGen stock target to $16, maintains Buy ratingJanuary 31, 2025 | msn.comFY2029 Earnings Estimate for PepGen Issued By HC WainwrightPepGen Inc. (NASDAQ:PEPG - Free Report) - Investment analysts at HC Wainwright issued their FY2029 earnings per share estimates for shares of PepGen in a report issued on Thursday, January 30th. HC Wainwright analyst A. Fein forecasts that the company will post earnings per share of ($0.21) for tJanuary 31, 2025 | marketbeat.comCautiously Optimistic Buy Rating for PepGen Inc. Amid Safety Concerns and Positive Pipeline ProgressJanuary 31, 2025 | markets.businessinsider.comPepGen continues trials for DMD treatment, addresses safety concernsJanuary 31, 2025 | msn.comPepGen Inc. (PEPG) Gets a Buy from Stifel NicolausJanuary 31, 2025 | markets.businessinsider.comPepGen price target lowered to $16 from $26 at H.C. WainwrightJanuary 31, 2025 | markets.businessinsider.comPepGen stock plunges to 52-week low of $1.76 amid market challengesJanuary 31, 2025 | msn.comPepGen (NASDAQ:PEPG) Price Target Lowered to $16.00 at HC WainwrightHC Wainwright dropped their price target on PepGen from $26.00 to $16.00 and set a "buy" rating for the company in a report on Thursday.January 30, 2025 | marketbeat.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPGJanuary 28, 2025 | prnewswire.comPepGen stock hits 52-week low at $2.21 amid market challengesJanuary 21, 2025 | msn.comPepGen Inc. (NASDAQ:PEPG) Short Interest Down 14.1% in DecemberPepGen Inc. (NASDAQ:PEPG - Get Free Report) saw a large drop in short interest in December. As of December 31st, there was short interest totalling 694,200 shares, a drop of 14.1% from the December 15th total of 808,100 shares. Based on an average daily volume of 159,500 shares, the short-interest ratio is currently 4.4 days. Approximately 2.6% of the company's stock are short sold.January 16, 2025 | marketbeat.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPGJanuary 8, 2025 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPGJanuary 2, 2025 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. ...December 28, 2024 | gurufocus.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPGDecember 27, 2024 | prnewswire.comWedbush Forecasts PepGen's FY2028 Earnings (NASDAQ:PEPG)PepGen Inc. (NASDAQ:PEPG - Free Report) - Equities research analysts at Wedbush raised their FY2028 earnings per share (EPS) estimates for shares of PepGen in a report released on Monday, December 16th. Wedbush analyst L. Chico now expects that the company will post earnings of ($1.85) per shareDecember 19, 2024 | marketbeat.comFmr LLC Sells 327,160 Shares of PepGen Inc. (NASDAQ:PEPG)Fmr LLC decreased its position in shares of PepGen Inc. (NASDAQ:PEPG - Free Report) by 84.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 61,607 shares of the company's stock after selling 3December 19, 2024 | marketbeat.comNovo builds up manufacturing; Pepgen Duchenne trial put on holdDecember 17, 2024 | yahoo.comBofA downgrades PepGen to Underperform after clinical holdDecember 17, 2024 | markets.businessinsider.comPepGen stock down 22% on FDA clinical hold (update)December 17, 2024 | msn.comPepGen Announces Clinical Hold in the U.S. on IND Application to Initiate CONNECT2-EDO51 Phase 2 Study of PGN-EDO51 for Duchenne Muscular DystrophyDecember 17, 2024 | finance.yahoo.com Remove Ads Get PepGen News Delivered to You Automatically Sign up to receive the latest news and ratings for PEPG and its competitors with MarketBeat's FREE daily newsletter. Email Address PEPG Media Mentions By Week PEPG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PEPG News Sentiment▼0.310.78▲Average Medical News Sentiment PEPG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PEPG Articles This Week▼22▲PEPG Articles Average Week Remove Ads Get PepGen News Delivered to You Automatically Sign up to receive the latest news and ratings for PEPG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies INmune Bio News Tevogen Bio News Voyager Therapeutics News Eledon Pharmaceuticals News Inhibrx News AC Immune News DiaMedica Therapeutics News biote News SOPHiA GENETICS News Neurogene News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PEPG) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PepGen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PepGen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
